In fact, nearly 90% of sporadic BCC and up to 33% of sporadic medulloblastomas show SHH pathway activation, caused most commonly by inactivating mutations in PTCH1 or more rarely by activating mutations in SMO [184,185]. This evidence concerns the gene SHH and skin basal cell carcinoma.